Optimal product portfolio management is increasingly important for generic pharmaceutical companies in today’s intensely competitive environment. Strategic focus and front-level risk management are imperative for ensuring maximum value. This article addresses the key considerations and risks for ensuring a successful portfolio in a dynamic pharmaceutical landscape.